Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of South Alabama
With
ProHealth Care, Inc
Women's Cancer Care
University of Tennessee Cancer Institute
Arizona Oncology Associates
Sarasota Memorial Hospital
Florida Hospital Cancer Institute
Crescent City Physicians, Inc.
Sanford USD Medical Center
Monongalia General Hospital
Ochsner Health System
Sacred Heart Health System
Tennessee Valley Gynecologic Oncology
Washington University School of Medicine
Augusta University
Tulane University Health Sciences Center
Cancer Center of South Florida
Mayo Clinic
Marshall University
Indiana University
University of Arizona
St. Luke's Hospital and Health Network, Pennsylvania
Mercy Medical Center
Age
50–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
1. Must be fully consented to the collection of the samples in writing (completed consent forms).
2. Age Criteria: Women age 50 and older who are post menopausal (defined as 12 months past last menstrual period).
3. Must have: Diagnosis of an adnexal mass or a suspicion of ovarian cancer, or a suspected fallopian tube or primary peritoneal cancer.
4. Must have a uterus and cervix.
5. Surgery for the adnexal mass must be anticipated. (Only patients with an adnexal mass requiring surgery will be eligible).
You may not be if
1. Any subject who has a condition that would increase the risk associated with the standard sampling procedures (Such as a pap smear, or cotton swab in vagina)
2. Prior hysterectomy.
3. Absence of adnexal mass.
4. Primary diagnosis of a cancer other than ovarian, primary peritoneal or fallopian tube.
5. Patients with grossly visible cervical cancer.
6. Previous/recent treatment for any invasive gynecologic cancer.
7. Recent chemotherapy within the prior 2 years. (recent neoadjuvant chemotherapy for ovarian cancer would exclude the patient from participation).
8. Cervical conization within the prior 6 months.
9. History of Radiation therapy to the pelvis, vagina or cervix.
10. Obvious advanced stage cancer (Stage III or IV) on presentation, if known prior to specimen collection.
Clareo Health | A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus
